Filamin 2 (FLN2): A Muscle-specific Sarcoglycan Interacting Protein

@article{Thompson2000Filamin2,
  title={Filamin 2 (FLN2): A Muscle-specific Sarcoglycan Interacting Protein},
  author={T. Thompson and Y. Chan and A. Hack and M. Brosius and M. Rajala and H. Lidov and E. McNally and Simon C Watkins and L. Kunkel},
  journal={Journal of Cell Biology},
  year={2000},
  volume={148},
  pages={115-126}
}
Mutations in genes encoding for the sarcoglycans, a subset of proteins within the dystrophin–glycoprotein complex, produce a limb-girdle muscular dystrophy phenotype; however, the precise role of this group of proteins in the skeletal muscle is not known. To understand the role of the sarcoglycan complex, we looked for sarcoglycan interacting proteins with the hope of finding novel members of the dystrophin–glycoprotein complex. Using the yeast two-hybrid method, we have identified a skeletal… Expand

Figures and Tables from this paper

Identification of functional domains in sarcoglycans essential for their interaction and plasma membrane targeting.
TLDR
A detailed structural analysis of sarcoglycans is presented using deletion study, limited proteolysis and co-immunoprecipitation to suggest that the formation of a stable complex is necessary but not sufficient for plasma membrane targeting and provide evidence that the beta/delta-sarcoglycan core can associate with the C-terminus of dystrophin. Expand
DYSTROPHIN PROTEIN COMPLEX ASSEMBLY IN LIVING CELLS
TLDR
Data show the DPC follows a systematic and sequential assembly process, where proper integration, delivery and deposition of each protein into the complex is dependent on several protein-protein associations that in turn allow appropriate trafficking and assembly at the plasma membrane. Expand
Sub-physiological sarcoglycan expression contributes to compensatory muscle protection in mdx mice.
TLDR
The results suggest that sub-physiological sarcoglycan expression plays a critical role in ameliorating muscle disease in mdx mice and speculate that low-level sarcoglycans expression may represent a useful strategy to palliate DMD. Expand
Indications for a Novel Muscular Dystrophy Pathway
TLDR
The two Ig-like domains of the recently described α-actinin–binding Z-disc protein myotilin were found to interact directly with this filamin domain, indicating that the amino-terminal end of γ-filamin may be indirectly anchored to α-Actinin in the Z- Disc via myotILin. Expand
Deficiency in Kelch protein Klhl31 causes congenital myopathy in mice.
TLDR
A role for Klhl31 in the maintenance of skeletal muscle structure is highlighted and insight into the mechanisms underlying congenital myopathies is provided, including Filamin-C (FlnC) for ubiquitination and degradation. Expand
Sarcoglycanopathies: molecular pathogenesis and therapeutic prospects
TLDR
This review summarises the etiopathogenesis of sarcoglycanopathies and highlights the quality control machinery as a potential pharmacological target for therapy of these genetic disorders. Expand
Syncoilin, an intermediate filament-like protein linked to the dystrophin associated protein complex in skeletal muscle
  • C. Moorwood
  • Biology, Medicine
  • Cellular and Molecular Life Sciences
  • 2008
TLDR
The aims of this article are to review current knowledge about syncoilin and to discuss its possible functions in skeletal muscle, finding that it may be important for muscle regeneration in response to injury. Expand
Chapter 3 - Sarcoglycanopathies
TLDR
The clinical phenotype associated with sarcoglycanopathies is characterized by a slowly progressive proximal muscle weakness with onset during childhood in most cases and treatment is symptomatic and aims at amelioration of locomotor, respiratory, and cardiac manifestations of the disease. Expand
Integrins, muscle agrin and sarcoglycans during muscular inactivity conditions: an immunohistochemical study.
TLDR
The results showed the existence of a cascade mechanism which provoke a loss of regulatory effects of muscle activity on costameres, due to loss of muscle and neural agrin, and could determine a quantitative modification of transmembrane receptors and loss of alpha7B could be replaced and reinforced by enhanced expression of the alpha7A integrin to restore muscle fiber viability. Expand
Desmuslin, an intermediate filament protein that interacts with α-dystrobrevin and desmin
TLDR
These findings suggest that DMN may serve as a direct linkage between the extracellular matrix and the Z-discs (through plectin) and may play an important role in maintaining muscle cell integrity. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 64 REFERENCES
Molecular Organization of Sarcoglycan Complex in Mouse Myotubes in Culture
TLDR
The proposed model of their interactions helps to explain some of the emerging data on the consequences of mutations in the individual sarcoglycans, their effect on the complex, and potentially the clinical course of muscular dystrophies. Expand
Association of dystrophin and an integral membrane glycoprotein
TLDR
The results indicate that the function of dystrophin could be to link this glycop protein to the underlying cytoskeleton and thus help either to preserve membrane stability or to keep the glycoprotein non-uniformly distributed in the sarcolemma. Expand
Caveolin-3 in muscular dystrophy.
TLDR
It is shown that caveolin-3 co-purifies with dystrophin, and that a fraction of caveolin -3 is a dyStrophin-associated protein, suggesting that these are not benign polymorphisms and instead are disease-causing mutations. Expand
β–sarcoglycan (A3b) mutations cause autosomal recessive muscular dystrophy with loss of the sarcoglycan complex
TLDR
The isolation of cDNAs encoding the 43 kD sarcoglycan protein β–sarcoglycan (A3b) and the localization of the human gene to chromosome 4q12 are reported and a young girl with ARMD with truncating mutations on both alleles is described. Expand
Syntrophin binds to an alternatively spliced exon of dystrophin
TLDR
A COOH-terminal 37-kD fragment of beta 1-syntrophin sufficient to interact with translated dystrophin and its homologues is found, suggesting that the dystrophicin binding site occurs on a region that is conserved among the three syntrophin Homologues. Expand
γ-Sarcoglycan Deficiency Leads to Muscle Membrane Defects and Apoptosis Independent of Dystrophin
TLDR
It is demonstrated that sarcoglycan loss was sufficient and that dystrophin loss was not necessary to cause membrane defects and apoptosis, and that programmed cell death contributes to myofiber degeneration. Expand
Loss of the sarcoglycan complex and sarcospan leads to muscular dystrophy in beta-sarcoglycan-deficient mice.
TLDR
The data suggest that loss of the sarcoglycan complex and sarcospan alone is sufficient to cause muscular dystrophy, that beta-sarcoglycan is an important protein for formation ofThe sarcoglycans complex associated with sarcospans and that the role of the sarcasticoglycancomplex and sarcOSPan may be to strengthen the dystrophin axis connecting the basement membrane with the cytoskeleton. Expand
Glycoprotein complex anchoring dystrophin to sarcolemma.
TLDR
It is of the opinion that the complex of A2.A4 among various possible ones is the most important to anchor dystrophin to sarcolemma. Expand
Integrins (alpha7beta1) in muscle function and survival. Disrupted expression in merosin-deficient congenital muscular dystrophy.
Mutations in genes coding for dystrophin, for alpha, beta, gamma, and delta-sarcoglycans, or for the alpha2 chain of the basement membrane component merosin (laminin-2/4) cause various forms ofExpand
Mutations That Disrupt the Carboxyl-Terminus of γ-Sarcoglycan Cause Muscular Dystrophy
TLDR
Four patients with a severe muscular dystrophy phenotype were identified with homozygous, frameshifting mutations in gamma-sarcoglycan, and two of the four have microdeletions that disrupt the distal carboxyl-terminus of Gamma-sARCoglycan yet result in a complete absence of gamma-and beta-sparoglycan suggesting the importance of this region for stability of the sarcoglycan complex. Expand
...
1
2
3
4
5
...